Similar articles for PMID: 11699689

Year	Number of Results
1994	1
1997	1
1999	1
2001	3
2002	2
2003	3
2004	5
2005	3
2006	7
2007	9
2008	9
2009	5
2013	1
2015	5
2016	1
2019	2
2020	2
2021	1
2024	0

1

Seed implant brachytherapy for prostate cancer.

D'Souza D, Zelefsky MJ. D'Souza D, et al. CMAJ. 2001 Oct 16;165(8):1003-4. CMAJ. 2001. PMID: 11699689 Free PMC article. No abstract available.

2

Seed implant brachytherapy for prostate cancer.

Halperin R. Halperin R. CMAJ. 2001 Oct 16;165(8):1003; author reply 1004. CMAJ. 2001. PMID: 11699690 Free PMC article. No abstract available.

3

Iodine seed prostate brachytherapy: an alternative first-line choice for early prostate cancer.

Langley SE, Laing RW. Langley SE, et al. Prostate Cancer Prostatic Dis. 2004;7(3):201-7. doi: 10.1038/sj.pcan.4500727. Prostate Cancer Prostatic Dis. 2004. PMID: 15184864 Review.

4

Is an 192Ir permanent seed implant feasible for prostate brachytherapy?

Glasgow GP, Dogan N, Mohideen N. Glasgow GP, et al. Brachytherapy. 2002;1(4):195-203. doi: 10.1016/S1538-4721(02)00097-1. Brachytherapy. 2002. PMID: 15062167

5

Permanent prostate brachytherapy for Japanese men: results from initial 100 patients with prostate cancer.

Okaneya T, Nishizawa S, Nakayama T, Kamigaito T, Hashida I, Hosaka N. Okaneya T, et al. Int J Urol. 2007 Jul;14(7):602-6. doi: 10.1111/j.1442-2042.2007.01782.x. Int J Urol. 2007. PMID: 17645602

6

Selecting patients for exclusive permanent implant prostate brachytherapy: the experience of the Paris Institut Curie/Cochin Hospital/Necker Hospital group on 809 patients.

Cosset JM, Flam T, Thiounn N, Gomme S, Rosenwald JC, Asselain B, Pontvert D, Henni M, Debre B, Chauveinc L. Cosset JM, et al. Int J Radiat Oncol Biol Phys. 2008 Jul 15;71(4):1042-8. doi: 10.1016/j.ijrobp.2007.11.056. Epub 2008 Mar 12. Int J Radiat Oncol Biol Phys. 2008. PMID: 18339488

7

Clinical predictors of Gleason score upgrading: implications for patients considering watchful waiting, active surveillance, or brachytherapy.

Kulkarni GS, Lockwood G, Evans A, Toi A, Trachtenberg J, Jewett MA, Finelli A, Fleshner NE. Kulkarni GS, et al. Cancer. 2007 Jun 15;109(12):2432-8. doi: 10.1002/cncr.22712. Cancer. 2007. PMID: 17497649 Free article.

8

The impact of hormone therapy on post-implant dosimetry and outcome following Iodine-125 implant monotherapy for localised prostate cancer.

Ash D, Al-Qaisieh B, Bottomley D, Carey B, Joseph J. Ash D, et al. Radiother Oncol. 2005 Jun;75(3):303-6. doi: 10.1016/j.radonc.2005.03.015. Radiother Oncol. 2005. PMID: 15890423

9

Factors influencing treatment decisions in patients with low risk prostate cancer referred to a brachytherapy clinic.

Taussky D, Liu A, Abrahamowicz M, Léger-Bélanger E, Bahary JP, Beauchemin MC, Nguyen TV, Donath D, Saad F. Taussky D, et al. Can J Urol. 2008 Dec;15(6):4415-20. Can J Urol. 2008. PMID: 19046495

10

Dosimetry accuracy as a function of seed localization uncertainty in permanent prostate brachytherapy: increased seed number correlates with less variability in prostate dosimetry.

Su Y, Davis BJ, Furutani KM, Herman MG, Robb RA. Su Y, et al. Phys Med Biol. 2007 Jun 7;52(11):3105-19. doi: 10.1088/0031-9155/52/11/012. Epub 2007 May 10. Phys Med Biol. 2007. PMID: 17505092

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

58 results

Results by year